ATP2B4 and pancreatic ductal adenocarcinoma: In the case of PMCA4, this pump has emerged as a modifier of cancer from the cell migration and metastasis point of view, suppressing dissemination in melanoma and gastric models, while being upregulated in pancreatic ductal adenocarcinoma [42].